Themis Medicare Limited has informed the Exchange about General Updates
THEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Preferential Issue Committee of Themis Medicare approved the allotment of 45,95,795 Convertible Equity Warrants to Vividhmargi Investments Private Limited on a preferential basis. The minimum issue price was determined at Rs. 99.76 per warrant (certified by a Practicing Company Secretary), which has been rounded off to Rs. 100.00 per warrant. The issue is subject to shareholder approval via postal ballot, with e-voting scheduled between February 26 and March 27, 2026. The relevant date for the preferential issue is February 25, 2026. This follows the Board's earlier approval on February 13, 2026.
If approved by shareholders, this preferential warrant issue will lead to potential equity dilution for existing shareholders when the warrants are eventually exercised and converted into shares. The allotment to Vividhmargi Investments, likely a promoter-group entity, suggests the issue is aimed at infusion of capital while maintaining promoter control. Stock price may react based on perceived fairness of the Rs. 100 pricing relative to current market price.